[{"id":"84bcb047-48bf-41ab-8d01-d2bc5efa22fb","acronym":"","url":"https://clinicaltrials.gov/study/NCT05737706","created_at":"2023-02-21T15:01:29.871Z","updated_at":"2024-07-02T16:35:28.495Z","phase":"Phase 1/2","brief_title":"Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation","source_id_and_acronym":"NCT05737706","lead_sponsor":"Mirati Therapeutics Inc.","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS mutation • KRAS G12D • KRAS G12","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • KRAS G12D • KRAS G12"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MRTX1133"],"overall_status":"Recruiting","enrollment":" Enrollment 386","initiation":"Initiation: 03/20/2023","start_date":" 03/20/2023","primary_txt":" Primary completion: 08/30/2026","primary_completion_date":" 08/30/2026","study_txt":" Completion: 08/30/2026","study_completion_date":" 08/30/2026","last_update_posted":"2023-11-21"}]